The wroth of neoadjuvant treatment in conjunction with resection as multimodality therapy (MMT) for stage IIB non-small cell lung cancer is still controversial.
Impact of Multimodality Treatment Sequence on Survival in Stage IIB Non-Small Cell Lung Cancer
Submitted by: Christopher Anderson
Source: The Annals of Thoracic Surgery
Source URL: https://doi.org/10.1016/j.athoracsur.2020.12.008
Keywords:
Author(s): Sean M. Stokes, MD, MS
Nader N. Massarweh, MD, MPH
John R. Stringham, MD
Thomas K. Varghese Jr., MD, MS
